LNKB vs CARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 16, 2026

LNKB

57.7
AI Score
VS
CARE Wins

CARE

64.8
AI Score

Investment Advisor Scores

LNKB

58score
Recommendation
HOLD

CARE

65score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric LNKB CARE Winner
Forward P/E 0 13.6612 Tie
PEG Ratio 0 0 Tie
Revenue Growth -16.3% 260.0% CARE
Earnings Growth -61.4% 900.8% CARE
Tradestie Score 57.7/100 64.8/100 CARE
Profit Margin 28.4% 41.8% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY CARE

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.